KU School of Medicine-Wichita

Embark 2020-2021

Issue link: http://kusm-wichita.uberflip.com/i/1372819

Contents of this Issue

Navigation

Page 26 of 31

25 KU Wichita Subspecialty Pediatrics Clinic opens in the Wesley Medical Arts Tower. 2010 First class of KU School of Pharmacy-Wichita students starts. Donna Sweet, M.D., moves her practice back to the Wichita campus. 2010 2011 Tiany Schwasinger-Schmidt, M.D., Ph.D., director of the Center for Clinical Research, and Krystal Anderson, medical assistant at the Center for Health Care CLINICAL TRIAL P H A S E S OF A P H A S E 1 20–100 Participants Healthy volunteers or people with the condition Length of Study Several months Purpose of Study Safety & dosage 70% of drugs move to the next phase P H A S E 2 Several Hundred Participants Volunteers with the condition Purpose of Study Ecacy & side eects 33% of drugs move to the next phase Length of Study Several months to 2 years P H A S E 3 300–3,000 Participants Volunteers with the condition Length of Study 1 to 4 years Purpose of Study Ecacy & monitor adverse reactions 25 –30% of drugs move to the next phase P H A S E 4 Several Thousand Participants Volunteers with the condition Purpose of Study Ecacy & side eects

Articles in this issue

view archives of KU School of Medicine-Wichita - Embark 2020-2021